NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative...

Por Antoine Brouquet, Jean-Baptiste Bachet, Florence Huguet, Mehdi Karoui, Pascal Artru, Charles Sabbagh, Jérémie H. Lefèvre, Dewi Vernerey, Christophe Mariette, Eric Vicaut, Stephane Benoist, on behalf the FRENCH , GRECCAR, PRODIGE study groups
Publicado em 2020-05-01

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external...

Por Knaebel, HP, Märten, A, Schmidt, J, Hoffmann, K, Seiler, C, Lindel, K, Schmitz-Winnenthal, H, Fritz, S, Herrmann, T, Goldschmidt, H, Mansmann, U, Debus, J, Diehl, V, Büchler, MW
Publicado em 2005

1503. Engraftment of Investigational Microbiome Drug, SER-262, in Subjects Receiving Vancomycin Is Associated with Reduced Rates of Recurrence after Primary Clostridium Difficile Infection (CDI)

Por Ford, Christopher, Litcofsky, Kevin, McGovern, Barbara, Pardi, Darrell, Nathan, Richard, Hansen, Val, Brennan, Robert, Pullman, John, Bernardo, Patricia, Tomlinson, Amelia, Horgan, Kevin, Bryant, Jessica, Walsh, Emily, Rodriguez, Michelle, Rogalin, Henry, Wang, Elaine, Henn, Matt
Publicado no Open Forum Infect Dis (2019)

The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane...

Por Lerario, Antonio M., Worden, Francis P., Ramm, Carole A., Hasseltine, Elizabeth A., Stadler, Walter M., Else, Tobias, Shah, Manisha H., Agamah, Edem, Rao, Krishna, Hammer, Gary D.
Publicado no Horm Cancer (2014)

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS

Por GORDON, PAUL H., CHEUNG, YING-KUEN, LEVIN, BRUCE, ANDREWS, HOWARD, DOORISH, CAROLYN, MACARTHUR, ROBERT B., MONTES, JACQUELINE, BEDNARZ, KATE, FLORENCE, JULAINE, ROWIN, JULIE, BOYLAN, KEVIN, MOZAFFAR, TAHSEEN, TANDAN, RUP, MITSUMOTO, HIROSHI, KELVIN, ELIZABETH A., CHAPIN, JOHN, BEDLACK, RICHARD, RIVNER, MICHAEL, MCCLUSKEY, LEO F., PESTRONK, ALAN, GRAVES, MICHAEL, SORENSON, ERIC J., BAROHN, RICHARD J., BELSH, JERRY M., LOU, JAU-SHIN, LEVINE, TODD, SAPERSTEIN, DAVID, MILLER, ROBERT G., SCELSA, STEPHEN N.
Publicado no Amyotroph Lateral Scler (2008)

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia

Por Stein, Anthony S., Larson, Richard A., Schuh, Andre C., Stevenson, William, Lech-Maranda, Ewa, Tran, Qui, Zimmerman, Zachary, Kormany, William, Topp, Max S.
Publicado no Blood Adv (2018)

Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

Por Jamil, Kazi M., Haque, Rashidul, Rahman, Ridwanur, Faiz, M. Abul, Bhuiyan, Abu Toha Md. Rezwanul Haque, Kumar, Amresh, Hassan, Syed Misbah, Kelly, Heather, Dhalaria, Pritu, Kochhar, Sonali, Desjeux, Philippe, Bhuiyan, Mohammad A. A., Khan, Mohammed M., Ghosh, Raj Shankar
Publicado no PLoS Negl Trop Dis (2015)

ATIM-09. CLINICAL TRIAL IN PROGRESS: A STUDY OF NEOADJUVANT AND ADJUVANT VB-111 FOR TREATMENT OF RECURRENT GBM

Por Cloughesy, Timothy, Butowski, Nicholas, Harats, Dror, Rachmilewitz Minei, Tamar, Wen, Patrick
Publicado no Neuro Oncol (2019)

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

Por Esposito Abate, Riziero, Pasquale, Raffaella, Sacco, Alessandra, Piccirillo, Maria Carmela, Morabito, Alessandro, Bidoli, Paolo, Finocchiaro, Giovanna, Chiari, Rita, Foltran, Luisa, Buosi, Roberta, Tiseo, Marcello, Giannetta, Laura, Battiloro, Ciro, Fasola, Gianpiero, Romano, Gianpiero, Ciuffreda, Libero, Frassoldati, Antonio, de Marinis, Filippo, Cappuzzo, Federico, Normanno, Nicola
Publicado no Cancers (Basel) (2019)

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma

Por Lee, Victor H.F., Kwong, Dora L.W., Lam, Ka-On, Lai, Yu-Ching, Li, Yun, Tong, Chi-Chung, Ho, Patty P.Y., Chan, Wing-Lok, Wong, Lai-San, Leung, Dennis K.C., Chan, Sum-Yin, Chan, Fong-Ting, Leung, To-Wai, Lee, Anne W.M.
Publicado no Medicine (Baltimore) (2017)

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

Por Molina, Jean-Michel, Clotet, Bonaventura, van Lunzen, Jan, Lazzarin, Adriano, Cavassini, Matthias, Henry, Keith, Kulagin, Valeriv, Givens, Naomi, Brennan, Clare, de Oliveira, Carlos Fernando
Publicado no J Int AIDS Soc (2014)

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

Por Riziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, Maria Carmela Piccirillo, Alessandro Morabito, Paolo Bidoli, Giovanna Finocchiaro, Rita Chiari, Luisa Foltran, Roberta Buosi, Marcello Tiseo, Laura Giannetta, Ciro Battiloro, Gianpiero Fasola, Gianpiero Romano, Libero Ciuffreda, Antonio Frassoldati, Filippo de Marinis, Federico Cappuzzo, Nicola Normanno
Publicado em 2019-09-01